Gallant Pet, founded in 2018 by Aaron Hirschhorn and headquartered in San Diego, California, is dedicated to advancing veterinary care through innovative stem cell therapies. The company focuses on retrieving and preserving stem and regenerative cells from pets, particularly dogs, to treat wounds and other veterinary diseases. Gallant Pet aims to provide pet owners with cutting-edge treatment options that leverage the latest advancements in stem cell science.
Notable affiliated individuals include founder Aaron Hirschhorn, who has been instrumental in steering the company's mission. Gallant Pet has made significant strides in veterinary medicine, with several clinical trials in progress and a robust pipeline of upcoming trials. The company’s efforts have positioned it as a leader in the field of veterinary stem cell therapy, making a substantial impact on pet healthcare by offering advanced treatment solutions that improve the quality of life for pets.
